vTv醫療 VTVT 深 滬
已收盤 08-01 16:00:00 美东时间
14.575
-0.375
-2.51%
華盛通- 最 高14.575
- 今 開14.55
- 成交量 2579股
- 最 低 14.54
- 昨 收 14.95
- 總市值 3814.57万
- 52周最高 26.99
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 12.58
- 委 比 -84.83%
- 總股本 261.72万
- 歷史最高 560.00
- 量 比 1.82
- 振 幅 0.23%
- 歷史最低 7.38
- 每 手 1
- 風險率 5.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
vTv Therapeutics Inc. announced that its management, including CEO Paul Sekhri, CMO Thomas Strack, CSO Carmen Valcarce, and CFO Michael Tung, will participate in H.C. Wainwright’s virtual “HCW@Home” Series on Thursday, June 12, 2025, at 10:00 AM ET. The event will include a fireside chat accessible via a webcast link. vTv is a biopharmaceutical company developing cadisegliatin, a potential first-in-class oral therapy for type 1 diabetes.
06-11 12:00
国内GLP-1创新减重药物研究首登国际顶刊 今年有望与“同门”替尔泊肽在中国市场“同台竞技”
近日，国内GLP-1类创新减重药物玛仕度肽在中国超重或肥胖受试者中的Ⅲ期临床研究（GLORY-1）登上国际知名期刊《新英格兰医学杂志》，这是全球首个且唯一申报上...
05-30 16:41
vTv Therapeutics Appoints Michael Tung As EVP And CFO, Effective Immediately
vTv Therapeutics Inc. (NASDAQ:VTVT), a late-stage biopharmaceutical company, today announced the appointment of Michael Tung, M.D., MBA as Executive Vice President and Chief Financial Officer, effective immediately. Dr.
05-19 21:04
vTv Therapeutics Highlights Cadisegliatin’s Potential for Diabetes
vTv Therapeutics ( ($VTVT) ) has issued an announcement. On May 16, 2025, vTv T...
05-16 21:28
vTv Therapeutics Q1 EPS $(0.77) Beats $(0.92) Estimate
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.92) by 16.3 percent. This is a 34.19 percent increase over losses of $(1.17) per share from
05-16 04:13
vTv Therapeutics Appoints Barry Brown as Interim CFO
vTv Therapeutics ( ($VTVT) ) has provided an announcement. On April 11, 2025, v...
04-12 06:25
美股大行评级 | 超多美股遭下调评级！高盛：下调美国航空集团评级至"卖出"，目标价从16美元下调至8美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117013356914663424.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持FTC Solar(FTCI)"买入"评级，目标价从1.5美元升至5美元</p> <p>• 摩根士丹利：维持艾伯维(ABBV)"超配"评级，目标价从239美元升至241美
04-10 09:00
VTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
HIGH POINT, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasd...
2024-12-03 05:05
vTv Therapeutics Q3 EPS $(0.88) Up From $(3.19) YoY
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.88) per share. This is a 72.41 percent increase over losses of $(3.19) per share from the same period last year.
2024-11-13 06:14
vTv Therapeutics Faces License Agreement Termination
vTv Therapeutics ( ($VTVT) ) has issued an update. OnKure Therapeutics plans to...
2024-10-26 05:01
